UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number: 811-23165
CION ARES DIVERSIFIED CREDIT FUND
(Exact name of registrant as specified in charter)
3 Park Avenue, 36th Floor
New York, NY 10016
(Address of principal executive offices) (zip code)
Eric A. Pinero
3 Park Avenue, 36th Floor
New York, NY 10016
(Name and address of agent for service)
Copy to:
Michael A. Reisner
Mark Gatto
CION Ares Management, LLC
3 Park Avenue, 36th Floor
New York, NY 10016
Richard Horowitz, Esq.
Matthew K. Kerfoot, Esq.
Dechert LLP
1095 Avenue of the Americas
New York, NY 10036
Registrant’s telephone number, including area code: (646) 845-2577
Date of fiscal year end: October 31
Date of reporting period: July 1, 2018 - June 30, 2019
Item 1. Proxy Voting Record.
Issuer |
| Security Description |
| Ticker |
| Primary ID |
| Held by CADEX? |
| Shareholder Meeting Date |
| Matter Voted On |
| Proposed By |
| Voted (Yes/No) |
| For or Against |
| For or Against Management |
Acadia Healthcare Co Inc. |
| Acadia Healthcare Co Inc. Common Stock |
| ACHC |
| 00404A109 |
| Yes |
| 5/2/2019 |
| Election of Directors, compensation of executive officers, frequency of advisory vote on executive officer compensation, and appointment of Ernst & Young LLP as independent accounting firm for FY 2019 |
| Issuer |
| Yes |
| For |
| For |
Coherus Biosciences Inc. |
| Coherus Biosciences Inc. Common Stock |
| CHRS |
| 19249H103 |
| Yes |
| 5/22/2019 |
| Election of Directors and appointment of Ernst & Young LLP as independent accounting firm for FY 2019 |
| Issuer |
| Yes |
| For |
| For |
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CION ARES DIVERSIFIED CREDIT FUND |
| |
|
| |
|
| |
By: | /s/ Michael A. Reisner |
|
| Michael A. Reisner |
|
| Co-President and Chief Executive Officer |
|
|
| |
|
| |
By: | /s/ Mark Gatto |
|
| Mark Gatto |
|
| Co-President and Chief Executive Officer |
|
|
| |
|
| |
Date: August 1, 2019 |
|